|Articles|May 15, 2015
FDA Comments on Continuous Manufacturing
Advertisement
Christine Moore, acting director in the Office of Process and Facilities at at FDA's Center for Drug Evaluation and Research, spoke with Pharmaceutical Technology at Interphex 2015 about advances in continuous manufacturing, regulatory concerns, and next steps.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
US Withdrawal From WHO Creates New Pharma Logistics Vulnerabilities
2
Cellares Secures $257M to Scale Global Cell Therapy Manufacturing
3
Halo Pharma Becomes Dedicated North American Drug Product CDMO
4
Repertoire Immune Medicines and Lilly Collaborate on Treatments for Autoimmune Diseases
5
